Chelsea Therapeutics International Ltd.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Chelsea Therapeutics has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other attractive players in the healthcare industry include Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), Gilead Sciences Inc. (NASDAQ: GILD) and TrovaGene, Inc. (NASDAQ: TROV) all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
CHELSEA THERAP (NASDAQ: CHTP): Free Stock Analysis Report
ENANTA PHARMA (NASDAQ: ENTA): Free Stock Analysis Report
GILEAD SCIENCES (NASDAQ: GILD): Free Stock Analysis Report
TROVAGENE INC (NASDAQ: TROV): Get Free Report
To read this article on Zacks.com click here.
Zacks Investment Research